Drug developer ViroPharma announced that Richard Morris no longer serves as chief accounting officer, as of June 20. Instead, he will remain with the company as vice president of financial planning and strategic analysis.

Drug developer ViroPharma announced that Richard Morris no longer serves as chief accounting officer, as of June 20. Instead, he will remain with the company as vice president of financial planning and strategic analysis.
We'll send a verification code to %EMAIL%.